Skip to content

NEWS

Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small cell lung cancer receiving 1st-line chemotherapy: a Phase 1b/randomized Phase 2 trial.

Weiss JM1, Csoszi T2, Maglakelidze M3, Hoyer RJ4, Beck JT5, Gomez MD6, Lowczak A7, Aljumaily R8, Lima CMR9, Boccia RV10, Hanna W11, Nikolinakos P12, Chiu VK13, Owonikoko TK14, Schuster SR15, Hussein MA16, Richards DA17, Sawrycki P18, Bulat I19, Hamm JT20, Hart LL21, Adler S22, Antal JM22, Lai AY22, Sorrentino JA22, Yang Z22, Malik RK22, Morris SR22, Roberts PJ22, Dragnev KH23; G1T28-02 Study Group.

 

https://www.ncbi.nlm.nih.gov/pubmed/31504118


QCCA Welcomes Stockton Hematology Oncology Medical Group!

QCCA Welcomes Stockton Hematology Oncology Medical Group!

Stockton Hematology Oncology was established in 1991 to provide comprehensive care for patients diagnosed with cancer and blood disorders.

With 4 locations in San Joaquin County, we offer a full spectrum of cancer care that focuses on prevention, screening, diagnosis and treatment of all cancers and blood diseases.

We are very excited to have Stockton Hematology Oncology join QCCA!